Alk-Abello AS (WBO:ALKB) Cyclically Adjusted PS Ratio: (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ALKB Alk-Abello AS WBO:ALKB
64 GF Score
Price €29.94
GF Value €27.41
Valuation Fairly Valued
View Full Analysis

What is Alk-Abello AS Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alk-Abello AS  (WBO:ALKB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Alk-Abello AS Cyclically Adjusted PS Ratio Related Terms


Alk-Abello AS Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Cyclically Adjusted PS Ratio Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.72 5.84 5.85 8.50 11.20

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 9.50 10.36 11.20 9.72

WBO:ALKB vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Alk-Abello AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Cyclically Adjusted PS Ratio falls into.


WBO:ALKB
64GF Score
Alk-Abello AS WBO:ALKB
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Alk-Abello AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Alk-Abello AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.084/121.6800*121.6800
=1.084

Current CPI (Mar. 2026) = 121.6800.

Alk-Abello AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.505 100.600 0.611
201609 0.434 100.200 0.527
201612 0.506 100.300 0.614
201703 0.539 101.200 0.648
201706 0.472 101.200 0.568
201709 0.451 101.800 0.539
201712 0.476 101.300 0.572
201803 0.463 101.700 0.554
201806 0.452 102.300 0.538
201809 0.343 102.400 0.408
201812 0.489 102.100 0.583
201903 0.529 102.900 0.626
201906 0.479 102.900 0.566
201909 0.455 102.900 0.538
201912 0.530 102.900 0.627
202003 0.580 103.300 0.683
202006 0.466 103.200 0.549
202009 0.467 103.500 0.549
202012 0.603 103.400 0.710
202103 0.627 104.300 0.731
202106 0.556 105.000 0.644
202109 0.573 105.800 0.659
202112 0.660 106.600 0.753
202203 0.667 109.900 0.738
202206 0.669 113.600 0.717
202209 0.549 116.400 0.574
202212 0.691 115.900 0.725
202303 0.712 117.300 0.739
202306 0.693 116.400 0.724
202309 0.636 117.400 0.659
202312 0.763 116.700 0.796
202403 0.859 118.400 0.883
202406 0.824 118.500 0.846
202409 0.831 118.900 0.850
202412 0.918 118.900 0.939
202503 0.922 120.200 0.933
202506 0.934 120.700 0.942
202509 0.914 121.600 0.915
202512 1.044 121.200 1.048
202603 1.084 121.680 1.084

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of €29.94 is trading 9.2% above its estimated GF Value™ of €27.41. GuruFocus considers Alk-Abello AS to be Fairly Valued.

Key valuation signals for WBO:ALKB:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €27.41 vs. price of €29.94 (9.2% above fair value)
  • GF Score™: 64/100

No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
64GF Score

Get the complete analysis for WBO:ALKB

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.94
Price
€27.41
GF Value